CARLOMAGNO, Chiara
CARLOMAGNO, Chiara
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
Cancro del colon-retto
2007 Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models
2012 Bianco, Roberto; R., Rosa; L., Nappi; Formisano, Luigi; V., Damiano; C., D'Amato; A. P., de Maio; Marciano, Roberta; Malapelle, Umberto; Troncone, Giancarlo; Carlomagno, Chiara; DE STEFANO, Alfonso; G., Tortora; DE PLACIDO, Sabino
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
2007 T., Suter; M., Procter; DJ Van, Veldhuisen; M., Muscholl; J., Bergh; Carlomagno, Chiara; T., Perren; R., Passalacqua; C., Bighin; J., Klijn; Ft, Ageev; E., Hiltre; J., Groetez; H., Iwata; M., Knap; M., Gnant; S., Muehlbauer; A., Spence; Rd, Gelber; MJ Piccart, Gebhart
Weekly docetaxel and capecitabine in the treatment of advanced gastric cancer: a phase II study
2006 M., Orditura; G., Aurilio; G., Galizia; Carlomagno, Chiara; E., Lieto; L., Vecchione; E., Martinelli; DE PLACIDO, Sabino; G., Catalano; F., Ciardiello; F., De Vita
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as initial treatment for metastatic colorectal cancer (TRIBE study): updated survival results and final molecular subgroups analyses.
2015 Fotios, Loupakis; Chiara, Cremolini; Carlotta, Antoniotti; Sara, Lonardi; Monica, Ronzoni; Alberto, Zaniboni; Giuseppe, Tonini; Lisa, Salvatore; Silvana, Chiara; Carlomagno, Chiara; Chiara, Banzi; Francesca, Negri; Lorenzo, Marcucci; Carlo, Barone; Gabriella, Fontanini; Nicla, Borrelli; Mirella, Giordano; Elisabetta, Macerola; Luca, Boni; Alfredo, Falcone
FOLFOXIRI plus bevacizumab (bev) versus FOLFIRI plus bev as first-line treatment of metastatic coloectal cancer (MCRC): results of the phase III tandomized TRIBE trial
2013 Luopakis, F; Cremolini, C; Masi, G; Lonardi, S; Zagonel, V; Trenta, P; Tomasello, G; Ronzoni, M; Ciuffreda, L; Zaniboni, A; Tonini, G; Buonadonna, A; Valsuani, C; Chiara, S; Carlomagno, Chiara; Boni, C; Marcucci, L; Boni, L; Falcone, A.
Risk factors for cancer-related venous thromboembolism in ambulatory patients.
2014 Chiara Alessandra, Cella; Arcopinto, Michele; Florian, Lordick; Carlomagno, Chiara; Elide, Matano; Katja, Muehlberg; Bruzzese, Dario; Roberto, Moretto; Laura, Attademo; Lucia, Raimondo; Haiko, Schloegl; Alfonso De, Stefano; Maren, Knoedler; Gertraud, Stocker; Maria, Gabrecht; DE PLACIDO, Sabino
Primary hepatic lymphoma in a patient with previous rectal adenocarcinoma: a case report and discussion ofetiopathogenesis and diagnostic tools
2012 Raimondo, Lucia; Ferrara, IDA LUCIA; DE STEFANO, Alfonso; Cella, CHIARA ALESSANDRA; D'Armiento, FRANCESCO PAOLO; Ciancia, Giuseppe; Moretto, Roberto; Amalia De, Renzo; Carlomagno, Chiara
Adjuvant treatment for locally advanced rectal cancer patients after pre-operative chemoradiotherapy: when, and for whom?
2014 DE STEFANO, Alfonso; Moretto, R; Bucci, Luigi; Pepe, S; Romano, Fj; Cella, Ca; Attademo, L; Rosanova, M; De Falco, S; Fiore, G; Raimondo, L; DE PLACIDO, Sabino; Carlomagno, Chiara
Ovarian metastasis following gallbladder carcinoma: a case report.
2010 Carlomagno, Chiara; Insabato, Luigi; Bifulco, Giuseppe; DE PLACIDO, Sabino; Lauria, R.
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer.
2003 DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; Carlomagno, Chiara; C., Gallo; F., Perrone; Pepe, Stefano; A., Ruggiero; Marinelli, Alfredo; Pagliarulo, Clorindo; Pettinato, Guido; G., Petrella; Bianco, ANGELO RAFFAELE
The first breast cancer screening program in southern Italy: preliminary results from three municipalities of the Naples Province.
1995 DE PLACIDO, Sabino; F., Nuzzo; F., Perrone; Carlomagno, Chiara; A., Noviello; P., Delrio; E., di Palma; M. T., Pini; P. L., Cerato; C., Bianco
First-line systemic therapy for metastatic breast cancer and management of pleural effusion.
1995 F., Perrone; Carlomagno, Chiara; DE PLACIDO, Sabino; Lauria, Rossella; A., Morabito; Bianco, ANGELO RAFFAELE
MULTIDISCIPLINARY APPROACH TO PATIENTS WITH MALIGNANT MELANOMA
2013 DELLA VITTORIA SCARPATI, Giuseppina; Fusciello, Celeste; Sabbatino, Francesco; Ferrose, S; Caponigro, F; Perri, F; Carlomagno, Chiara; Pepe, S.
Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study.
1990 DE PLACIDO, Sabino; C., Gallo; F., Perrone; Marinelli, Alfredo; C., Pagliarulo; Carlomagno, Chiara; Petrella, Giuseppe; M., D'Istria; Delrio, Giovanni; Bianco, ANGELO RAFFAELE
Human herpes virus associated with Hashimoto's thyroiditis
2013 Di Crescenzo, Vincenzo; D'Antonio, Antonio; Tonacchera, Massimo; Carlomagno, Chiara; Vitale, Mario
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience
2013 Moretto, Roberto; Raimondo, Lucia; DE STEFANO, Alfonso; Cella, CHIARA ALESSANDRA; Matano, E; DE PLACIDO, Sabino; Carlomagno, Chiara
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
2010 Correa, C; Mcgale, P; Taylor, C; Wang, Y; Clarke, M; Davies, C; Peto, R; Bijker, N; Solin, L; Darby, S; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; Carlomagno, Chiara; DE PLACIDO, Sabino
DNA-flow cytometry (ploidy and S-phase fraction) as prognostic factor in a retrospectine series of 515 primary breast cancer.
1995 Pepe, S.; Ruggiero, A.; DE LAURENTIIS, Michelino; Normanno, N.; Fiorentino, B.; Perrone, F.; Carlomagno, Chiara; DE PLACIDO, Sabino; Panico, L.; Pettinato, Guido; Borriello, G.; Bianco, ANGELO RAFFAELE
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.
1999 DE PLACIDO, Sabino; Lauria, Rossella; Carlomagno, Chiara; F., Perrone; DE LAURENTIIS, Michelino; C., Gallo; A., Martignetti; T., Bellelli; Limite, Gennaro; Petrella, Giuseppe; Bianco, ANGELO RAFFAELE
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Cancro del colon-retto | 2.1 Contributo in volume (Capitolo o Saggio) | 2007 | Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar | |
| Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models | 1.5 Abstract in rivista | 2012 | Bianco, Roberto; R., Rosa; L., Nappi; Formisano, Luigi; V., Damiano; C., D'Amato; A. P., de Maio; Marciano, Roberta; Malapelle, Umberto; Troncone, Giancarlo; Carlomagno, Chiara; DE STEFANO, Alfonso; G., Tortora; DE PLACIDO, Sabino | |
| Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial | 1.5 Abstract in rivista | 2007 | T., Suter; M., Procter; DJ Van, Veldhuisen; M., Muscholl; J., Bergh; Carlomagno, Chiara; T., Perren; R., Passalacqua; C., Bighin; J., Klijn; Ft, Ageev; E., Hiltre; J., Groetez; H., Iwata; M., Knap; M., Gnant; S., Muehlbauer; A., Spence; Rd, Gelber; MJ Piccart, Gebhart | |
| Weekly docetaxel and capecitabine in the treatment of advanced gastric cancer: a phase II study | 1.5 Abstract in rivista | 2006 | M., Orditura; G., Aurilio; G., Galizia; Carlomagno, Chiara; E., Lieto; L., Vecchione; E., Martinelli; DE PLACIDO, Sabino; G., Catalano; F., Ciardiello; F., De Vita | |
| FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as initial treatment for metastatic colorectal cancer (TRIBE study): updated survival results and final molecular subgroups analyses. | 1.5 Abstract in rivista | 2015 | Fotios, Loupakis; Chiara, Cremolini; Carlotta, Antoniotti; Sara, Lonardi; Monica, Ronzoni; Alberto, Zaniboni; Giuseppe, Tonini; Lisa, Salvatore; Silvana, Chiara; Carlomagno, Chiara; Chiara, Banzi; Francesca, Negri; Lorenzo, Marcucci; Carlo, Barone; Gabriella, Fontanini; Nicla, Borrelli; Mirella, Giordano; Elisabetta, Macerola; Luca, Boni; Alfredo, Falcone | |
| FOLFOXIRI plus bevacizumab (bev) versus FOLFIRI plus bev as first-line treatment of metastatic coloectal cancer (MCRC): results of the phase III tandomized TRIBE trial | 1.5 Abstract in rivista | 2013 | Luopakis, F; Cremolini, C; Masi, G; Lonardi, S; Zagonel, V; Trenta, P; Tomasello, G; Ronzoni, M; Ciuffreda, L; Zaniboni, A; Tonini, G; Buonadonna, A; Valsuani, C; Chiara, S; Carlomagno, Chiara; Boni, C; Marcucci, L; Boni, L; Falcone, A. | |
| Risk factors for cancer-related venous thromboembolism in ambulatory patients. | 1.5 Abstract in rivista | 2014 | Chiara Alessandra, Cella; Arcopinto, Michele; Florian, Lordick; Carlomagno, Chiara; Elide, Matano; Katja, Muehlberg; Bruzzese, Dario; Roberto, Moretto; Laura, Attademo; Lucia, Raimondo; Haiko, Schloegl; Alfonso De, Stefano; Maren, Knoedler; Gertraud, Stocker; Maria, Gabrecht; DE PLACIDO, Sabino | |
| Primary hepatic lymphoma in a patient with previous rectal adenocarcinoma: a case report and discussion ofetiopathogenesis and diagnostic tools | 1.1 Articolo in rivista | 2012 | Raimondo, Lucia; Ferrara, IDA LUCIA; DE STEFANO, Alfonso; Cella, CHIARA ALESSANDRA; D'Armiento, FRANCESCO PAOLO; Ciancia, Giuseppe; Moretto, Roberto; Amalia De, Renzo; Carlomagno, Chiara | |
| Adjuvant treatment for locally advanced rectal cancer patients after pre-operative chemoradiotherapy: when, and for whom? | 1.1 Articolo in rivista | 2014 | DE STEFANO, Alfonso; Moretto, R; Bucci, Luigi; Pepe, S; Romano, Fj; Cella, Ca; Attademo, L; Rosanova, M; De Falco, S; Fiore, G; Raimondo, L; DE PLACIDO, Sabino; Carlomagno, Chiara | |
| Ovarian metastasis following gallbladder carcinoma: a case report. | 1.1 Articolo in rivista | 2010 | Carlomagno, Chiara; Insabato, Luigi; Bifulco, Giuseppe; DE PLACIDO, Sabino; Lauria, R. | |
| Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. | 1.1 Articolo in rivista | 2003 | DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; Carlomagno, Chiara; C., Gallo; F., Perrone; Pepe, Stefano; A., Ruggiero; Marinelli, Alfredo; Pagliarulo, Clorindo; Pettinato, Guido; G., Petrella; Bianco, ANGELO RAFFAELE | |
| The first breast cancer screening program in southern Italy: preliminary results from three municipalities of the Naples Province. | 1.1 Articolo in rivista | 1995 | DE PLACIDO, Sabino; F., Nuzzo; F., Perrone; Carlomagno, Chiara; A., Noviello; P., Delrio; E., di Palma; M. T., Pini; P. L., Cerato; C., Bianco | |
| First-line systemic therapy for metastatic breast cancer and management of pleural effusion. | 1.1 Articolo in rivista | 1995 | F., Perrone; Carlomagno, Chiara; DE PLACIDO, Sabino; Lauria, Rossella; A., Morabito; Bianco, ANGELO RAFFAELE | |
| MULTIDISCIPLINARY APPROACH TO PATIENTS WITH MALIGNANT MELANOMA | 1.1 Articolo in rivista | 2013 | DELLA VITTORIA SCARPATI, Giuseppina; Fusciello, Celeste; Sabbatino, Francesco; Ferrose, S; Caponigro, F; Perri, F; Carlomagno, Chiara; Pepe, S. | |
| Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study. | 1.1 Articolo in rivista | 1990 | DE PLACIDO, Sabino; C., Gallo; F., Perrone; Marinelli, Alfredo; C., Pagliarulo; Carlomagno, Chiara; Petrella, Giuseppe; M., D'Istria; Delrio, Giovanni; Bianco, ANGELO RAFFAELE | |
| Human herpes virus associated with Hashimoto's thyroiditis | 1.1 Articolo in rivista | 2013 | Di Crescenzo, Vincenzo; D'Antonio, Antonio; Tonacchera, Massimo; Carlomagno, Chiara; Vitale, Mario | |
| FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience | 1.1 Articolo in rivista | 2013 | Moretto, Roberto; Raimondo, Lucia; DE STEFANO, Alfonso; Cella, CHIARA ALESSANDRA; Matano, E; DE PLACIDO, Sabino; Carlomagno, Chiara | |
| Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. | 1.1 Articolo in rivista | 2010 | Correa, C; Mcgale, P; Taylor, C; Wang, Y; Clarke, M; Davies, C; Peto, R; Bijker, N; Solin, L; Darby, S; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; Carlomagno, Chiara; DE PLACIDO, Sabino | |
| DNA-flow cytometry (ploidy and S-phase fraction) as prognostic factor in a retrospectine series of 515 primary breast cancer. | 1.1 Articolo in rivista | 1995 | Pepe, S.; Ruggiero, A.; DE LAURENTIIS, Michelino; Normanno, N.; Fiorentino, B.; Perrone, F.; Carlomagno, Chiara; DE PLACIDO, Sabino; Panico, L.; Pettinato, Guido; Borriello, G.; Bianco, ANGELO RAFFAELE | |
| The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer. | 1.1 Articolo in rivista | 1999 | DE PLACIDO, Sabino; Lauria, Rossella; Carlomagno, Chiara; F., Perrone; DE LAURENTIIS, Michelino; C., Gallo; A., Martignetti; T., Bellelli; Limite, Gennaro; Petrella, Giuseppe; Bianco, ANGELO RAFFAELE |